Search

Your search keyword '"Antiprotozoal Agents pharmacology"' showing total 5,699 results

Search Constraints

Start Over You searched for: Descriptor "Antiprotozoal Agents pharmacology" Remove constraint Descriptor: "Antiprotozoal Agents pharmacology"
5,699 results on '"Antiprotozoal Agents pharmacology"'

Search Results

1. Cryptosporidium PI(4)K inhibitor EDI048 is a gut-restricted parasiticidal agent to treat paediatric enteric cryptosporidiosis.

2. Antitrypanosomal and antileishmanial activity of compounds from some Nigerian plants.

3. Chitosan/collagen biomembrane loaded with 2,3-dihydrobenzofuran for the treatment of cutaneous Leishmaniasis.

4. Blastocystis species growth inhibition in vitro by plant extracts.

5. N-substituted-4-(pyridin-4-ylalkyl)piperazine-1-carboxamides and related compounds as Leishmania CYP51 and CYP5122A1 inhibitors.

6. Effects of cardanol-based phospholipid analogs on Trichomonas vaginalis.

7. Effect of a thiohydantoin salt derived from l-Arginine on Leishmania amazonensis and infected cells: Insights from biological effects to molecular docking interactions.

8. Tri-aryl antimony(V) hydroximato and hydroxamato complexes: Combining lipophilic Sb(III/V) and hydroxamic acids in combating Leishmania.

9. CYP5122A1 encodes an essential sterol C4-methyl oxidase in Leishmania donovani and determines the antileishmanial activity of antifungal azoles.

10. A Divergent Synthesis of Numerous Pyrroloiminoquinone Alkaloids Identifies Promising Antiprotozoal Agents.

11. Characterizing Leishmania infantum-induced resistance to trivalent stibogluconate (SbIII) through deep proteomics.

12. Natural and Bioinspired Lipidic Alkynylcarbinols as Leishmanicidal, Antiplasmodial, Trypanocidal, Fungicidal, Antibacterial, and Antimycobacterial Agents.

13. Evaluation of anti-Toxoplasma effects of solid lipid nanoparticles carrying Cinnamon zeylanicum and Moringa oleifera oil extracts.

14. Pharmacophore Establishment and Optimization of Saturated 1,6-Naphthyridine-Fused Quinazolinones that Inhibit Meningoencephalitis-Causing Naegleria fowleri .

15. Discovery of a Series of Macrocycles as Potent Inhibitors of Leishmania Infantum .

16. Antimicrobial Peptides and Their Anti- Leishmanial Efficacies on Leishmania tropica Promastigotes In vitro .

17. 3-Alkoxy-1-Benzyl-5-Nitroindazole Derivatives Are Potent Antileishmanial Compounds.

18. C57BL/6 Peritoneal Macrophage Exosomes Improve Antileishmanial Functions of the RAW264.7 Cells.

19. Effects of Amphotericin B-Conjugated Functionalized Carbon Nanoparticles in the Treatment of Cutaneous Leishmaniasis.

20. Miltefosine induces reproductive toxicity during sperm capacitation by altering PI3K/AKT signaling pathway.

21. Auranofin is lethal against feline Tritrichomonas foetus in vitro but ineffective in cats with naturally occurring infection.

22. Investigational new drugs for the treatment of leishmaniasis.

23. Evaluation of the efficacy of Chitosan nanoparticles based on Rosuvastatin in the treatment of acute toxoplasmosis: An In vitro and In vivo study.

24. Anti-Acanthamoeba metallopharmaceuticals: Amoebicidal activity and synergistic effect of copper(II) coordination compound.

25. Emerging therapeutic avenues against Cryptosporidium: A comprehensive review.

26. Anti- Leishmania activity of the Mayan medicinal plant Thouinia paucidentata Radlk extracts.

27. Phytochemical, antileishmanial, antifungal and cytotoxic profiles of Thymelaea tartonraira (L.) All. extracts.

28. E-pharmacophore and deep learning based high throughput virtual screening for identification of CDPK1 inhibitors of Cryptosporidium parvum.

29. Phytochemical investigation of Chrysanthellum americanum Vatke and its constituents- a targeted approach for the treatment of leishmaniasis.

30. Hydrazinated geraniol derivatives as potential broad-spectrum antiprotozoal agents.

31. Computational evaluation of phytochemicals targeting DNA topoisomerase I in Leishmania donovani : molecular docking and molecular dynamics simulation studies.

32. Could metformin modulate the outcome of chronic murine toxoplasmosis?

33. Anti-leishmanial and cytotoxic compounds isolated from marine sponge Hemimycale sp.

34. Exploring the anti-protozoal mechanisms of Syzygium aromaticum phytochemicals targeting Cryptosporidium parvum lactate dehydrogenase through molecular dynamics simulations.

35. Repurposing FDA approved drugs against Sterol C-24 methyltransferase of Leishmania donovani: A dual in silico and in vitro approach.

36. Microemulsions strongly promoted the activity of α-bisabolol against different Leishmania species and its skin permeation.

37. Thiadiazine-thiones as inhibitors of leishmania pteridine reductase (PTR1) target: investigations and in silico approach.

38. 1,2,4-Oxadiazole Derivatives: Physicochemical Properties, Antileishmanial Potential, Docking and Molecular Dynamic Simulations of Leishmania infantum Target Proteins.

39. Approved drugs successfully repurposed against Leishmania based on machine learning predictions.

40. Identification and characterization of archaeal-type FAD synthase as a novel tractable drug target from the parasitic protozoa Entamoeba histolytica .

41. Integrated subtractive genomics and structure-based approach to unravel the therapeutic drug target of Leishmania species.

42. A Targeted and Protease-Activated Genetically Encoded Melittin-Containing Particle for the Treatment of Cutaneous and Visceral Leishmaniasis.

43. Development of Amphotericin B Decorated Gold Nanoparticles as a Promising Antileishmanial Nanoconjugate.

44. Revisiting the dipeptidyl carboxypeptidase inhibitor captopril as a source of pan anti-trypanosomatid agents.

45. Synthesis and activity of benzimidazole N-Acylhydrazones against Trypanosoma cruzi, Leishmania amazonensis and Leishmania infantum.

46. Deciphering Host-Parasite Interplay in Leishmania Infection through a One Health View of Proteomics Studies on Drug Resistance.

47. Synthesis and Biological Evaluation of Cyanoacrylamides and 5-Iminopyrrol-2-Ones Against Naegleria fowleri .

48. Phytochemical profiling and characterization of flavonoid derivatives from propolis sample and investigation of cytotoxic and antiprotozoal activities.

49. Hydrophobic binary mixtures containing amphotericin B as lipophilic solutions for the treatment of cutaneous leishmaniasis.

50. Encapsulation of Citrus sinensis essential oil and R-limonene in lipid nanocarriers: A potential strategy for the treatment of leishmaniasis.

Catalog

Books, media, physical & digital resources